MAGNIMS position papers
click on title to access pdf of article (only for member users)
otherwise click on pubmed link for full reference
Position papers published from 2015 to present time
Using Value of Optic Nerve MRI in Multiple Sclerosis Clinical Management: A MAGNIMS Position Paper and Future Perspectives. Sastre-Garriga J, Vidal-Jordana A, Toosy AT, Enzinger C, Granziera C, Frederiksen J, Ciccarelli O, Filippi M, Montalban X, Tintore M, Pareto D, Rovira À; MAGNIMS Study Group. Neurology. 2024 Aug 13;103(3):e209677.pubmed
Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis. Ciccarelli O, Barkhof F, Calabrese M, De Stefano N, Eshaghi A, Filippi M, Gasperini C, Granziera C, Kappos L, Rocca MA, Rovira À, Sastre-Garriga J, Sormani MP, Tur C, Toosy AT; as the MAGNIMS Study Group. Neurology. 2024 Jul 9;103(1):e209444.pubmed
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Wattjes MP, Ciccarelli O, Reich DS, Banwell B, de Stefano N, Enzinger C, Fazekas F, Filippi M, Frederiksen J, Gasperini C, Hacohen Y, Kappos L, Li DKB, Mankad K, Montalban X, Newsome SD, Oh J, Palace J, Rocca MA, Sastre-Garriga J, Tintoré M, Traboulsee A, Vrenken H, Yousry T, Barkhof F, Rovira À; Magnetic Resonance Imaging in Multiple Sclerosis study group; Consortium of Multiple Sclerosis Centres; North American Imaging in Multiple Sclerosis Cooperative MRI guidelines working group. Lancet Neurol. 2021 Aug;20(8):653-670.pubmed
MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Sastre-Garriga J, Pareto D, Battaglini M, Rocca MA, Ciccarelli O, Enzinger C, Wuerfel J, Sormani MP, Barkhof F, Yousry TA, De Stefano N, Tintoré M, Filippi M, Gasperini C, Kappos L, Río J, Frederiksen J, Palace J, Vrenken H, Montalban X, Rovira À; MAGNIMS study group. Nat Rev Neurol. 2020 Mar;16(3):171-182.pubmed
Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge. Gasperini C, Prosperini L, Tintoré M, Sormani MP, Filippi M, Rio J, Palace J, Rocca MA, Ciccarelli O, Barkhof F, Sastre-Garriga J, Vrenken H, Frederiksen JL, Yousry TA, Enzinger C, Rovira A, Kappos L, Pozzilli C, Montalban X, De Stefano N; and the MAGNIMS Study Group. Neurology. 2019 Jan 22;92(4):180-192.pubmed
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI. Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H; MAGNIMS Study Group. Neuroimage Clin. 2018 Apr 26;19:466-475.pubmed
The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N, Palace J; MAGNIMS study group. Nat Rev Neurol. 2018 Apr;14(4):199-213.pubmed
Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations. De Stefano N, Giorgio A, Tintoré M, Pia Amato M, Kappos L, Palace J, Yousry T, Rocca MA, Ciccarelli O, Enzinger C, Frederiksen J, Filippi M, Vrenken H, Rovira À; MAGNIMS study group. Mult Scler. 2018 Feb;24(2):214-221.pubmed
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, Rovira A, Sastre-Garriga J, Tintorè M, Frederiksen JL, Gasperini C, Palace J, Reich DS, Banwell B, Montalban X, Barkhof F; MAGNIMS Study Group. Lancet Neurol. 2016 Mar;15(3):292-303.
pubmed
pubmed
MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process Rovira À, Wattjes MP, Tintoré M, Tur C, Yousry TA, Sormani MP, De Stefano N, Filippi M, Auger C, Rocca MA, Barkhof F, Fazekas F, Kappos L, Polman C, Miller D, Montalban X; MAGNIMS study group. Nat Rev Neurol. 2015 Aug;11(8):471-82.
pubmed
pubmed
MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis – establishing disease prognosis and monitoring patients Wattjes MP, Rovira À, Miller D, Yousry TA, Sormani MP, de Stefano MP, Tintoré M, Auger C, Tur C, Filippi M, Rocca MA, Fazekas F, Kappos L, Polman C, Frederik Barkhof, Xavier Montalban; MAGNIMS study group. Nat Rev Neurol. 2015 Oct;11(10):597-606.
pubmed
pubmed
Position papers published before 2015
Recommendations to improve imaging and analysis in longitudinal MS studies Vrenken H, Jenkinson M, Horsfield MA, Battaglini M, van Schijndel RA, Rostrup E, Geurts JJ, Fisher E, Zijdenbos A, Ashburner J, Miller DH, Filippi M, Fazekas F, Rovaris M, Rovira A, Barkhof F, de Stefano N; MAGNIMS Study Group. J Neurol. 2013 Oct;260(10):2458-71.
pubmed
pubmed
Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Geurts JJ, Roosendaal SD, Calabrese M, Ciccarelli O, Agosta F, Chard DT, Gass A, Huerga E, Moraal B, Pareto D, Rocca MA, Wattjes MP, Yousry TA, Uitdehaag BM, Barkhof F; MAGNIMS Study Group. Neurology. 2011 Feb 1;76(5):418-24.
pubmed
pubmed
MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials. Barkhof F, Simon JH, Fazekas F, Rovaris M, Kappos L, de Stefano N, Polman CH, Petkau J, Radue EW, Sormani MP, Li DK, O’Connor P, Montalban X, Miller DH, Filippi M. Nat Rev Neurol. 2011 Dec 6;8(1):13-21.
pubmed
pubmed
MRI criteria for MS in patients with clinically isolated syndromes. Montalban X, Tintoré M, Swanton J, Barkhof F, Fazekas F, Filippi M, Frederiksen J, Kappos L, Palace J, Polman C, Rovaris M, de Stefano N, Thompson A, Yousry T, Rovira A, Miller DH. Neurology. 2010 Feb 2;74(5):427-34
pubmed
pubmed
Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. De Stefano N, Filippi M, Miller D, Pouwels PJ, Rovira A, Gass A, Enzinger C, Matthews PM, Arnold DL. Neurology. 2007 Nov 13;69(20):1942-52
pubmed
pubmed
MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”. Charil A, Yousry TA, Rovaris M, Barkhof F, De Stefano N, Fazekas F, Miller DH, Montalban X, Simon JH, Polman C, Filippi M. Lancet Neurol. 2006 Oct;5(10):841-52
pubmed
pubmed
Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Miller DH, Filippi M, Fazekas F, Frederiksen JL, Matthews PM, Montalban X, Polman CH. Ann Neurol. 2004 Aug;56(2):273-8
pubmed
pubmed
Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis. Horsfield MA, Barker GJ, Barkhof F, Miller DH, Thompson AJ, Filippi M. J Magn Reson Imaging. 2003 Apr;17(4):389-97
pubmed
pubmed
Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Thompson AJ, Montalban X, Barkhof F, Brochet B, Filippi M, Miller DH, Polman CH, Stevenson VL, McDonald WI. Ann Neurol. 2000 Jun;47(6):831-5
pubmed
pubmed
The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Fazekas F, Barkhof F, Filippi M, Grossman RI, Li DK, McDonald WI, McFarland HF, Paty DW, Simon JH, Wolinsky JS, Miller DH. Neurology. 1999 Aug 11;53(3):448-56
pubmed
pubmed
Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Filippi M, Horsfield MA, Adèr HJ, Barkhof F, Bruzzi P, Evans A, Frank JA, Grossman RI, McFarland HF, Molyneux P, Paty DW, Simon J, Tofts PS, Wolinsky JS, Miller DH. Ann Neurol. 1998 Apr;43(4):499-506
pubmed
pubmed
Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials. Barkhof F, Filippi M, Miller DH, Tofts P, Kappos L, Thompson AJ. J Neurol. 1997 Feb;244(2):76-84
pubmed
pubmed